ARTICLE | Clinical News
CytRx preclinical data
January 17, 2005 8:00 AM UTC
In rat models of diabetes either genetically predisposed to Type II diabetes or by inhibiting insulin production, arimoclomol significantly inhibited the production of glucose in the liver. The hydrox...